Table 2.

Follow-up, disease-specific and overall survival for patients with localized prostate cancer per treatment modality (brachytherapy, prostatectomy and external beam radiotherapy)

	Brachytherapy	Prostatectomy	EBRT	Total
No. of patients	1694	1353	336	3383
Follow-up (years, mean, 95 % CI)	7.9 (7.7–8.0)	9.1 (8.8–9.3)	7.1 (6.8–7.4)	8.3 (8.1–8.4)
10 year DSS (95 % CI)	91 % (90–92)	96 % (95–97)	93 % (90–95)	94 % (93–95)
10 year OS (95 % CI)	72 % (70–74)	87 % (85–89)	77 % (72–81)	79 % (78–80)

DSS disease-specific survival, OS overall survival